Liverpool ChiroChem

Liverpool, United Kingdom Founded: 2014 • Age: 12 yrs Acquired By XtalPi
Small organic molecules are supplied for biotech and pharmaceutical RD.
Annual revenue - Latest available
Total funding $11.1M 6 rounds
Employees 14 Tracked headcount
Investors 7 Known backers
Products 1 Services tracked
Competitors 9 Brand Intelligence

About Liverpool ChiroChem

Liverpool ChiroChem is a company based in Liverpool (United Kingdom) founded in 2014 was acquired by XtalPi in June 2025. Liverpool ChiroChem has raised $11.07 million across 6 funding rounds from investors including Gov.uk, XtalPi and Maven Capital Partners. The company has 14 employees as of December 31, 2018. Liverpool ChiroChem offers products and services including PACE™ Platform. Liverpool ChiroChem operates in a competitive market with competitors including Sai Life Sciences, Acies Bio, SpiroChem, IRBM and Personal Chemistry, among others.

  • Headquarter Liverpool, United Kingdom
  • Employees 14 as on 31 Dec, 2018
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Liverpool Chirochem Limited
  • Date of Incorporation 18 Feb, 2014
  • Jurisdiction WIGAN, ENGLAND
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $11.07 M (USD)

    in 6 rounds

  • Latest Funding Round
    $2.52 M (USD), Series A

    Nov 10, 2022

  • Investors
    Gov.uk

    & 6 more

  • Employee Count
    14

    as on Dec 31, 2018

  • Acquired by
    XtalPi

    (Jun 13, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Liverpool ChiroChem

Liverpool ChiroChem offers a comprehensive portfolio of products and services, including PACE™ Platform.

Product name locked
Category locked
Primary

Facilitates development of small molecule drugs using chiral libraries.

People of Liverpool ChiroChem

Headcount 10-50
Employee Profiles 17
Board Members and Advisors 3
Employee Profiles
People
Luke Elliott
Senior Team Leader
People
Omar Jaber
Research Chemist
People
Tony Huxley
Head, Business Development
People
Tami Warnock
Business Development Manager

Unlock access to complete

Board Members and Advisors
people
Steve Djuric
Scientific Advisor
people
Jianliang Xiao
Scientific Advisor
people
Brian Cox
Scientific Advisor

Unlock access to complete

Funding Insights of Liverpool ChiroChem

Liverpool ChiroChem has successfully raised a total of $11.07M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $2.52 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Liverpool ChiroChem

Liverpool ChiroChem has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Gov.uk, XtalPi and Maven Capital Partners.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital funding is provided by Praetura Ventures.
Locked Locked Locked
Deepbridge Capital is focused on tax-efficient investment opportunities.
Locked Locked Locked
Multiple sectors are targeted for private equity investments.
Locked Locked Locked
Premium access

Investor details for Liverpool ChiroChem

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Liverpool ChiroChem

Investments
Premium access

Investment portfolio details for Liverpool ChiroChem

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Liverpool ChiroChem

Premium access

Detailed financials for Liverpool ChiroChem

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Liverpool Chirochem Comparisons

Liverpool ChiroChem Primary company
Description
Small organic molecules are supplied for biotech and pharmac...
Location
Liverpool, United Kingdom
Founded Year
2014
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
14
As of 2018
Premium access

Peer comparison for Liverpool ChiroChem

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Liverpool ChiroChem

Liverpool ChiroChem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sai Life Sciences, Acies Bio, SpiroChem, IRBM and Personal Chemistry, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
Locked Locked Locked
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries
Locked Locked Locked
Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry
Locked Locked Locked
Integrated drug discovery and preclinical development services are provided.
Locked Locked Locked
Coherent Synthesis is developed for medicinal and combinatorial chemistry applications.
Premium access

Detailed competitors of Liverpool ChiroChem

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Liverpool Chirochem

Premium access

Complete news archive for Liverpool ChiroChem

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Liverpool ChiroChem

Liverpool ChiroChem was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Liverpool ChiroChem is headquartered in Liverpool, United Kingdom.

Liverpool ChiroChem is a funded company, having raised a total of $11.07M across 6 funding rounds to date.

As of Dec 31, 2018, the latest employee count at Liverpool ChiroChem is 14.

Liverpool ChiroChem was founded in 2014 and is based in Liverpool, United Kingdom. Operations center on the production and supply of small organic molecules, including building blocks, fragments, and screening compounds, with an initial emphasis on (a)chiral piperidines for drug discovery and development. Technology draws from asymmetric hydrogenation and Pd-coupling research. Collaborative services are offered to optimize key steps in synthetic routes for biotech and pharmaceutical clients.

Liverpool ChiroChem's top competitors include Sai Life Sciences, Acies Bio and IRBM.

Liverpool ChiroChem offers PACE™ Platform.

Liverpool ChiroChem has 7 investors. Key investors include Gov.uk, XtalPi, Maven Capital Partners, Praetura Ventures, and Deepbridge Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available